Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Option B+: ART Safety and Durability During First and Subsequent Pregnancies

NCT02249962 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT02249962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02249962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Option B+: ART Safety and Durability During First and Subsequent Pregnancies
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
September 30, 2020
Enrollment
12,011 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, infant exposure to efavirenz